The latest from OTC Perspectives
McNeil Prepares Market Return for Key OTC Products in 2012
McNeil Prepares Market Return for Key OTC Products in 2012
Tuesday, 31 January 2012, 01:10 PM
After suffering a 6.7% decline in 2011 for their over-the-counter business unit, Johnson & Johnson is planning a return to the marketplace. According to a Drug Store News report, Chairman and CEO William Weldon admitted that “reclaiming lost marketshare across its OTC franchises will be an uphill battle.” However, he confirmed during the Q4 earnings call that several products have already returned to store shelves, including some with new packaging innovations, such as a flow-restrictor to reduce children’s dosing errors.
To read the Drug Store News story, click here.
Related articles
Cough and Cold OTC Market to See Stable Growth in Sales
From 2007 to 2012, the Cough and Cold OTC industry will increase about 1.2% annually to $2.3 billion in revenue, according to a new report from IBISWorld. This can be
Pharmacists Still Underutilized Despite Extensive Knowledge
Only approximately 1 in 3 consumers (35%) ask a pharmacist questions regarding an OTC medication, compared to half of those (51%) filling a prescription product. The
FDA Requirements Not Enough Regarding Safety of Supplements
A draft guidance by the FDA for dietary supplement manufacturers are “too weak,” wrote Dr. Pieter Cohen in a recent issue of the New England Journal of Medicine.
Supplement Advertisers Warned for Non-Compliant Advertising
The Natural Products Foundation (NPF) alerted the Federal Trade Commission (FTC) to 22 dietary supplement advertisers that were not in compliance with marketing
OTC/HBA National Advertising Award Winners Announced
Verona, NJ [May 17, 2011] - OTC Perspectives, Inc. revealed the winners of the 3rd annual OTC/HBA National Advertising Awards last week during a celebratory cocktail
| ABOUT SSL CERTIFICATES |
